Elucida Oncology - Crunchbase Company Profile & Funding

Q: Who invested in Elucida Oncology?

Elucida Oncology is funded by Lynx Capital.

Q: When was the last funding round for Elucida Oncology?

Elucida Oncology closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Elucida Oncology raised to date?

Elucida Oncology has raised obfuscated.

Overview

Elucida Oncology

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Elucida Oncology

CB Rank

37469

Elucida Oncology develops targeted C'Dot Drug Conjugates (CDCs) for patients with primary solid tumor and metastatic cancer.

Founded

obfuscation

Private

Venture - Series Unknown

Monmouth Junction, New Jersey, United States

1-10

www.elucidaoncology.com/

Biotechnology

Health Care

Medical

Oncology

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Gregory Adams: CSO
Past Role: Sesen Bio, CSO
Greg Adams: Chief Scientific Officer
Past Role: Sesen Bio, Chief Scientific Officer

Details

Legal Name

Elucida Oncology, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Michelle Bradbury, Ulrich Wiesner

About the Company

Elucida Oncology focuses on transforming outcomes for patients with primary solid tumors and metastatic cancer. The company utilizes the novel target or clear capabilities of its ultra-small C-Dot cancer-targeting particle platform across diagnostic imaging, surgical, and a wide range of therapeutic applications.

Phone Number

646-701-5391

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

C'Dot Drug Conjugates (CDCs)

Targeted drug conjugates designed to treat primary solid tumors and metastatic cancer by delivering therapeutic agents directly to cancer cells.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Elucida Oncology	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Lynx Capital	—	Venture Round - Elucida Oncology	—
Lynx Capital	—	Venture Round - Elucida Oncology	—
Lynx Capital	—	Venture Round - Elucida Oncology	—
Lynx Capital	—	Venture Round - Elucida Oncology	—
Lynx Capital	—	Venture Round - Elucida Oncology	—